| The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery. | |
| | |
MedLine Citation:
|
PMID: 1434717 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effectiveness of the University of Wisconsin solution on extended myocardial preservation was examined in this study using phosphorus 31-nuclear magnetic resonance spectroscopy. Isolated perfused rat hearts were arrested and stored in four preservation solutions: group 1, modified Krebs-Henseleit solution; group 2, modified St. Thomas' Hospital solution; group 3, oxygenated modified St. Thomas' Hospital solution containing 11 mmol/L glucose; and group 4, University of Wisconsin solution. The changes in myocardial high energy phosphate profiles and the intracellular pH values were measured during 12 hours of cold (4 degrees C) global ischemia and 90 minutes of normothermic reperfusion. Following ischemia, the hearts were assessed for hemodynamic recovery and myocardial water content. During ischemia, adenosine triphosphate depletion was observed in all groups; however, after 5 hours of ischemia, the adenosine triphosphate levels were significantly higher in group 3 compared with the other groups (adenosine triphosphate levels at 6 hours in mumol/gm dry weight: group 3, 7.6; group 4, 3.2; group 2, < 1; p < 0.025). The tissue water content at the end of ischemia was lower with the University of Wisconsin solution compared with the modified St. Thomas' Hospital solution or the oxygenated modified St. Thomas' Hospital solution (in ml/gm dry weight: group 4, 3.0; group 2, 4.4; group 3, 3.9; p < 0.05). The adenosine triphosphate repletion during reperfusion was greater with the University of Wisconsin solution compared with the modified St. Thomas' Hospital solution or the oxygenated modified St. Thomas' Hospital solution (12 mumol/gm dry weight in group 4; 8.1 in group 2; 9.0 in group 3; p < 0.05). Similar findings were obtained for the recovery of left ventricular pressure (in percent of preischemic control: group 4, 70%; group 2, 42%; group 3, 52%; p < 0.01) and coronary flow (group 4, 61%; group 2, 49%; group 3, 49%; p < 0.05). These data suggest that preservation with the University of Wisconsin solution affords improved hemodynamic recovery, enhanced adenosine triphosphate repletion, and reduced tissue edema upon reperfusion; however, oxygenated St. Thomas' Hospital solution with glucose is associated with the preservation of higher myocardial adenosine triphosphate levels during prolonged cold global ischemia. In conclusion, these data indicate that the University of Wisconsin solution might improve graft tolerance of ischemia in clinical heart transplantation. |
| | |
Authors:
|
M Karck; A Vivi; M Tassini; H Schwalb; N Askenasy; G Navon; J B Borman; G Uretzky |
Related Documents
:
|
9104837 - Interactive effects of k+, acid, norepinephrine, and ischemia on the heart: implication... 4094037 - Effects of propranolol and diltiazem on carnitine derivatives and acyl coa in ischemic ... 8063867 - Electron paramagnetic resonance (epr) detection of nitric oxide produced during forebra... 18417547 - Exercise-induced protection against myocardial apoptosis and necrosis: mnsod, calcium-h... 2923057 - Paradoxical elevation of threshold to angina pectoris by cold pressor test in men with ... 20711437 - Functional mobility and balance in community-dwelling elderly submitted to multisensory... |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: The Journal of thoracic and cardiovascular surgery Volume: 104 ISSN: 0022-5223 ISO Abbreviation: J. Thorac. Cardiovasc. Surg. Publication Date: 1992 Nov |
Date Detail:
|
Created Date: 1992-12-11 Completed Date: 1992-12-11 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0376343 Medline TA: J Thorac Cardiovasc Surg Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1356-64 Citation Subset: AIM; IM |
Affiliation:
|
Joseph Lunenfeld Cardiac Surgery Research Center, Hadassah University Hospital, Jerusalem, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenosine Adenosine Triphosphate / analysis Allopurinol Animals Bicarbonates / pharmacology Body Water Calcium Chloride / pharmacology Cardioplegic Solutions / pharmacology* Glutathione Heart / drug effects*, physiology Hemodynamics / drug effects Hydrogen-Ion Concentration Insulin Magnesium / pharmacology Magnetic Resonance Spectroscopy Male Myocardial Ischemia / etiology, physiopathology Myocardium / chemistry Organ Preservation / methods* Organ Preservation Solutions* Phosphocreatine / analysis Phosphorus / diagnostic use Potassium Chloride / pharmacology Raffinose Rats Rats, Sprague-Dawley Sodium Chloride / pharmacology Solutions / pharmacology* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Bicarbonates; 0/Cardioplegic Solutions; 0/Organ Preservation Solutions; 0/Solutions; 0/St. Thomas' Hospital cardioplegic solution; 0/University of Wisconsin-lactobionate solution; 10043-52-4/Calcium Chloride; 11061-68-0/Insulin; 315-30-0/Allopurinol; 512-69-6/Raffinose; 56-65-5/Adenosine Triphosphate; 58-61-7/Adenosine; 67-07-2/Phosphocreatine; 70-18-8/Glutathione; 7439-95-4/Magnesium; 7447-40-7/Potassium Chloride; 7647-14-5/Sodium Chloride; 7723-14-0/Phosphorus |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The use of combined antegrade-retrograde infusion of blood cardioplegic solution in pediatric patien...
Next Document: Crystalloid cardioplegia and hypothermia do not impair endothelium-dependent relaxation or damage va...